Paul Jude Tonna, Director at BioRestorative Therapies, Inc. (BRTX), bought 70,000 shares at $0.27 ($19K) on 2019-08-28, disclosed to the SEC on 2019-08-29.
Open-market purchase of $19k BRTX by Director. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade D.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $0.28 | 35,000 | $10K | 50.9% |
| 2 | $0.27 | 35,000 | $9K | 49.1% |
| Total | $0.28 avg | 70,000 | $19K | 100% |
| Filing → |